These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 36069612)

  • 1. Pulmonary hypertension screening in children with sickle cell disease.
    Chan KH; Rizvi SH; De Jesus-Rojas W; Stark JM; Mosquera RA; Prada-Ruiz AC; Gonzales T; Brown DL; Menon NM; Nguyen TT; Jon CK; Yadav A
    Pediatr Blood Cancer; 2023 Jan; 70(1):e29980. PubMed ID: 36069612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiopulmonary imaging, functional and laboratory studies in sickle cell disease associated pulmonary hypertension.
    van Beers EJ; Nur E; Schaefer-Prokop CM; Mac Gillavry MR; van Esser JW; Brandjes DP; Kappers-Klunne MC; Duits AJ; Muskiet FA; Schnog JJ; Biemond BJ;
    Am J Hematol; 2008 Nov; 83(11):850-4. PubMed ID: 18819095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-terminal pro-brain natriuretic peptide levels and risk of death in sickle cell disease.
    Machado RF; Anthi A; Steinberg MH; Bonds D; Sachdev V; Kato GJ; Taveira-DaSilva AM; Ballas SK; Blackwelder W; Xu X; Hunter L; Barton B; Waclawiw M; Castro O; Gladwin MT;
    JAMA; 2006 Jul; 296(3):310-8. PubMed ID: 16849664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated tricuspid regurgitation velocity in congenital hemolytic anemias: Prevalence and laboratory correlates.
    Yates AM; Joshi VM; Aygun B; Moen J; Smeltzer MP; Govindaswamy D; Dowdy J; Cotton A; Kang G; Ware RE; Hankins JS
    Pediatr Blood Cancer; 2019 Jul; 66(7):e27717. PubMed ID: 30907497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective appraisal of pulmonary hypertension in children with sickle cell disease.
    Sedrak A; Rao SP; Miller ST; Hekmat V; Rao M
    J Pediatr Hematol Oncol; 2009 Feb; 31(2):97-100. PubMed ID: 19194191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary hypertension in patients with sickle cell/beta thalassemia: incidence and correlation with serum N-terminal pro-brain natriuretic peptide concentrations.
    Voskaridou E; Tsetsos G; Tsoutsias A; Spyropoulou E; Christoulas D; Terpos E
    Haematologica; 2007 Jun; 92(6):738-43. PubMed ID: 17550845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-terminal natriuretic peptide and ventilation-perfusion lung scan in sickle cell disease and thalassemia patients with pulmonary hypertension.
    Mokhtar GM; Adly AA; El Alfy MS; Tawfik LM; Khairy AT
    Hemoglobin; 2010; 34(1):78-94. PubMed ID: 20113292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tricuspid regurgitant jet velocity elevation and its relationship to lung function in pediatric sickle cell disease.
    Liem RI; Nevin MA; Prestridge A; Young LT; Thompson AA
    Pediatr Pulmonol; 2009 Mar; 44(3):281-9. PubMed ID: 19205056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevation of tricuspid regurgitant jet velocity, a marker for pulmonary hypertension in children with sickle cell disease.
    Ambrusko SJ; Gunawardena S; Sakara A; Windsor B; Lanford L; Michelson P; Krishnamurti L
    Pediatr Blood Cancer; 2006 Dec; 47(7):907-13. PubMed ID: 16496290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary hypertension among 5 to 18 year old children with sickle cell anaemia in Nigeria.
    Sokunbi OJ; Ekure EN; Temiye EO; Anyanwu R; Okoromah CAN
    PLoS One; 2017; 12(9):e0184287. PubMed ID: 28910308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteinuria is associated with elevated tricuspid regurgitant jet velocity in children with sickle cell disease.
    Forrest S; Kim A; Carbonella J; Pashankar F
    Pediatr Blood Cancer; 2012 Jun; 58(6):937-40. PubMed ID: 21990235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and risk factors of elevated pulmonary artery pressures in children with sickle cell disease.
    Pashankar FD; Carbonella J; Bazzy-Asaad A; Friedman A
    Pediatrics; 2008 Apr; 121(4):777-82. PubMed ID: 18381543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large and medium-sized pulmonary artery obstruction does not play a role of primary importance in the etiology of sickle-cell disease-associated pulmonary hypertension.
    van Beers EJ; van Eck-Smit BL; Mac Gillavry MR; van Tuijn CF; van Esser JW; Brandjes DP; Kappers-Klunne MC; Duits AJ; Biemond BJ; Schnog JJ;
    Chest; 2008 Mar; 133(3):646-52. PubMed ID: 18198257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An official American Thoracic Society clinical practice guideline: diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell disease.
    Klings ES; Machado RF; Barst RJ; Morris CR; Mubarak KK; Gordeuk VR; Kato GJ; Ataga KI; Gibbs JS; Castro O; Rosenzweig EB; Sood N; Hsu L; Wilson KC; Telen MJ; Decastro LM; Krishnamurti L; Steinberg MH; Badesch DB; Gladwin MT;
    Am J Respir Crit Care Med; 2014 Mar; 189(6):727-40. PubMed ID: 24628312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and risk factors for pulmonary artery systolic hypertension among sickle cell disease patients in Nigeria.
    Aliyu ZY; Gordeuk V; Sachdev V; Babadoko A; Mamman AI; Akpanpe P; Attah E; Suleiman Y; Aliyu N; Yusuf J; Mendelsohn L; Kato GJ; Gladwin MT
    Am J Hematol; 2008 Jun; 83(6):485-90. PubMed ID: 18306362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary hypertension in children and young adults with sickle cell disease: evidence for familial clustering.
    Dahoui HA; Hayek MN; Nietert PJ; Arabi MT; Muwakkit SA; Saab RH; Bissar AN; Jumaa NM; Farhat FS; Dabbous IA; Bitar FF; Abboud MR
    Pediatr Blood Cancer; 2010 Mar; 54(3):398-402. PubMed ID: 19827138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effects of Hydroxyurea Therapy on the Six-Minute Walk Distance in Patients with Adult Sickle Cell Anemia: An Echocardiographic Study.
    Garadah T; Mandeel F; Jaradat A; Bin Thani K
    J Blood Med; 2019; 10():443-452. PubMed ID: 31920416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary hypertension in children and adolescents with sickle cell disease.
    Onyekwere OC; Campbell A; Teshome M; Onyeagoro S; Sylvan C; Akintilo A; Hutchinson S; Ensing G; Gaskin P; Kato G; Rana S; Kwagyan J; Gordeuk V; Williams J; Castro O
    Pediatr Cardiol; 2008 Mar; 29(2):309-12. PubMed ID: 17680298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased pulmonary artery pressures among adolescents with sickle cell disease.
    Suell MN; Bezold LI; Okcu MF; Mahoney DH; Shardonofsky F; Mueller BU
    J Pediatr Hematol Oncol; 2005 Dec; 27(12):654-8. PubMed ID: 16344670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NT-proBNP levels and cardiopulmonary function in children with sickle cell disease.
    Feld L; Fiorino EK; Aygun B; Appiah-Kubi A; Mitchell EC; Jackson S; Mehran R; Fishbein J; Santiago MT
    Pediatr Pulmonol; 2021 Feb; 56(2):495-501. PubMed ID: 33151019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.